Clinical Trial Update: EC50 of Dexmedetomidine in Deep Brain Stimulation Implantation of Patients With Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update examining the EC50 of dexmedetomidine during deep brain stimulation implantation in patients with Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: PD - Parkinson's Disease | Phase 4 | Status: UNKNOWN